Page last updated: 2024-09-05

darunavir and bilirubin

darunavir has been researched along with bilirubin in 4 studies

Compound Research Comparison

Studies
(darunavir)
Trials
(darunavir)
Recent Studies (post-2010)
(darunavir)
Studies
(bilirubin)
Trials
(bilirubin)
Recent Studies (post-2010) (bilirubin)
1,14822478025,9211,3375,871

Protein Interaction Comparison

ProteinTaxonomydarunavir (IC50)bilirubin (IC50)
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)3.3884
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.3183

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bower, M; Gazzard, B; Mandalia, S; Nelson, M; Rockwood, N1
Bernardino, JI; Carton, JA; Curran, A; Domingo, P; Ferrer, E; Gatell, JM; Gonzalez-Cordon, A; Gutierrez, F; Martinez, E; Murillas, J; Negredo, E; Peraire, J; Perez, I; Pich, J; Podzamczer, D; Portilla, J; Santos, I1
Cetin, I; Dalzero, S; Degli Antoni, A; Floridia, M; Francisci, D; Frisina, V; Liuzzi, G; Maccabruni, A; Masuelli, G; Ravizza, M; Sansone, M; Simonazzi, G; Tamburrini, E; Tassis, B1
Chan, WW; Li, M; Zucker, SD1

Trials

1 trial(s) available for darunavir and bilirubin

ArticleYear
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.
    HIV medicine, 2014, Volume: 15, Issue:6

    Topics: Adult; Atazanavir Sulfate; Bilirubin; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Darunavir; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Lipids; Male; Middle Aged; Oligopeptides; Prospective Studies; Pyridines; Ritonavir; RNA, Viral; Spain; Sulfonamides

2014

Other Studies

3 other study(ies) available for darunavir and bilirubin

ArticleYear
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir.
    AIDS (London, England), 2011, Aug-24, Volume: 25, Issue:13

    Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Bilirubin; Cohort Studies; Cyclopropanes; Darunavir; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Nephrolithiasis; Oligopeptides; Pyridines; Pyrimidinones; Retrospective Studies; Ritonavir; Sulfonamides

2011
Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study.
    The Journal of antimicrobial chemotherapy, 2018, 04-01, Volume: 73, Issue:4

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Cholesterol; Darunavir; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Treatment Outcome; Triglycerides; Viral Load

2018
Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.
    Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19

    Topics: Atazanavir Sulfate; Bilirubin; Cardiovascular Diseases; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Ischemic Stroke; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Time Factors

2020
chemdatabank.com